DuLac Farmaceutici, an Italian pharmaceutical company with over 30 years of industry experience, is advancing its U.S. retail strategy following its participation in the 2026 ECRM Vitamin, Weight Management & Sports Nutrition Session, held September 14-17 in Palm Beach Gardens, Florida. The company presented its Arnica, Dinaven, and Diosmin portfolio to U.S. buyers across health, specialty, food, drug, and mass retail channels, and is now continuing discussions to explore product assortment and distribution opportunities.
The move signals a broader push beyond DuLac's established e-commerce footprint in the United States. The company already offers its products to U.S. consumers through its Amazon storefront and OneLavi, providing a foundation of consumer feedback that could help prospective partners evaluate the portfolio. Notably, the company's Arnica Gel 98% listing on Amazon.com holds an average customer rating of 4.5 out of 5 stars, a metric that underscores existing consumer traction.
DuLac's portfolio includes its high-concentration Arnica Gel 98% range, topical leg-care products, and the Dinaven and Diosmin lines. These products reflect the company's Italian manufacturing expertise, botanical formulation capabilities, and its proprietary Arnica Montana Arricchita™ project, which involves advanced extraction technologies. The company's European pharmacy heritage and Italian production standards are central to its positioning as it seeks to build lasting relationships with U.S. partners.
Gabriele Bollani, Founder and CEO of DuLac Farmaceutici, emphasized the company's partner-focused approach: "Our priority following ECRM is to work with prospective partners to identify the DuLac products that best fit their customers and channels. We want to build lasting relationships by combining our Italian formulation and manufacturing expertise with a clear understanding of each partner's commercial needs."
The implications for the U.S. health and wellness market are significant. DuLac's expansion could introduce more European-style dermo-cosmetic and botanical products to American consumers, potentially increasing competition in categories such as topical pain relief and leg care. For retailers, the addition of an established Italian brand with a proven e-commerce track record may offer a way to differentiate their assortments. For consumers, it could mean greater access to products developed under pharmaceutical-grade manufacturing standards.
DuLac's long-term objective is to become a nationally recognized U.S. brand across multiple channels. Follow-up discussions with prospective partners will focus on product assortment, channel fit, and launch requirements. As the company continues these conversations, its ability to translate online success into brick-and-mortar distribution will be a key factor in its U.S. growth trajectory.
